Close Menu

NEW YORK (GenomeWeb) – GenMark Diagnostics announced today that it has submitted 510(k) applications to the US Food and Drug Administration for its ePlex sample-to-answer instrument and respiratory pathogen panel.

ePlex combines digital microfluidics with the firm's eSensor electrochemical detection technology to enable precise fluid management and accurate results, and the respiratory panel detects clinically relevant viral and bacterial targets from nasopharyngeal samples, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.